349 related articles for article (PubMed ID: 30883352)
1. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
[TBL] [Abstract][Full Text] [Related]
3. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Wang X
Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
[TBL] [Abstract][Full Text] [Related]
4. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
[TBL] [Abstract][Full Text] [Related]
5. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Lill CM; Rengmark A; Pihlstrøm L; Fogh I; Shatunov A; Sleiman PM; Wang LS; Liu T; Lassen CF; Meissner E; Alexopoulos P; Calvo A; Chio A; Dizdar N; Faltraco F; Forsgren L; Kirchheiner J; Kurz A; Larsen JP; Liebsch M; Linder J; Morrison KE; Nissbrandt H; Otto M; Pahnke J; Partch A; Restagno G; Rujescu D; Schnack C; Shaw CE; Shaw PJ; Tumani H; Tysnes OB; Valladares O; Silani V; van den Berg LH; van Rheenen W; Veldink JH; Lindenberger U; Steinhagen-Thiessen E; ; Teipel S; Perneczky R; Hakonarson H; Hampel H; von Arnim CAF; Olsen JH; Van Deerlin VM; Al-Chalabi A; Toft M; Ritz B; Bertram L
Alzheimers Dement; 2015 Dec; 11(12):1407-1416. PubMed ID: 25936935
[TBL] [Abstract][Full Text] [Related]
6. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
7. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous TREM2 mutations in frontotemporal dementia.
Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
[TBL] [Abstract][Full Text] [Related]
10.
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
[TBL] [Abstract][Full Text] [Related]
11. TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients.
Peplonska B; Berdynski M; Mandecka M; Barczak A; Kuzma-Kozakiewicz M; Barcikowska M; Zekanowski C
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):407-412. PubMed ID: 29557178
[TBL] [Abstract][Full Text] [Related]
12. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
[TBL] [Abstract][Full Text] [Related]
13. TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
Berdyński M; Ludwiczak J; Barczak A; Barcikowska-Kotowicz M; Kuźma-Kozakiewicz M; Dunin-Horkawicz S; Żekanowski C; Borzemska B
J Alzheimers Dis; 2022; 89(4):1211-1219. PubMed ID: 36031890
[TBL] [Abstract][Full Text] [Related]
14. The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population.
Arboleda-Bustos CE; Ortega-Rojas J; Mahecha MF; Arboleda G; Vásquez R; Pardo R; Arboleda H
Alzheimer Dis Assoc Disord; 2018; 32(4):305-308. PubMed ID: 30222607
[TBL] [Abstract][Full Text] [Related]
15. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
16. Differential role of triggering receptors expressed on myeloid cells 2 R47H in 3 neurodegenerative diseases based on a systematic review and meta-analysis.
Zhang B; Li R; Zhang Y; Gao X
Medicine (Baltimore); 2020 Jan; 99(5):e18921. PubMed ID: 32000403
[TBL] [Abstract][Full Text] [Related]
17. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of TREM2 variants in Chinese Han patients with sporadic Parkinson's disease.
Tan T; Song Z; Yuan L; Xiong W; Deng X; Ni B; Chen Y; Deng H
Neurosci Lett; 2016 Jan; 612():189-192. PubMed ID: 26704436
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.
Guerreiro R; Bilgic B; Guven G; Brás J; Rohrer J; Lohmann E; Hanagasi H; Gurvit H; Emre M
Neurobiol Aging; 2013 Dec; 34(12):2890.e1-5. PubMed ID: 23870839
[TBL] [Abstract][Full Text] [Related]
20. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.
Ayer AH; Wojta K; Ramos EM; Dokuru D; Chen JA; Karydas AM; Papatriantafyllou JD; Agiomyrgiannakis D; Kamtsadeli V; Tsinia N; Sali D; Gylys KH; Agosta F; Filippi M; Small GW; Bennett DA; Gearing M; Juncos JL; Kramer J; Lee SE; Yokoyama JS; Mendez MF; Chui H; Zarow C; Ringman JM; Kilic U; Babacan-Yildiz G; Levey A; DeCarli CS; Cotman CW; Boxer AL; Miller BL; Coppola G
Alzheimer Dis Assoc Disord; 2019; 33(4):327-330. PubMed ID: 31513029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]